Extracorporeal immunomodulation in patients with hepatocellular carcinoma with lymphokine activated killer cells.
Saibara
T
T
First Department of Internal Medicine, Kochi Medical School, Japan.
Fujikawa
M
M
Iwamura
S
S
Matsuura
Y
Y
Ido
E
E
Sakaeda
H
H
Tomita
A
A
Matsunaga
Y
Y
Maeda
T
T
Onishi
S
S
D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000276:immunology / Q000628:therapy*; D002986:Clinical Trials as Topic; D003602:Cytotoxicity, Immunologic; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007371:Interferon-gamma / Q000096:biosynthesis; D007376:Interleukin-2 / Q000627:therapeutic use; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology*; D007694:Killer Cells, Natural / Q000276:immunology; D008113:Liver Neoplasms / Q000276:immunology / Q000628:therapy*; D008297:Male; D008875:Middle Aged
D007376:Interleukin-2; D007371:Interferon-gamma